News

Article

Spectrum Chemical and BASF Enter Catalyst Agreement

Spectrum Chemical will provide BASF precious-metal-containing powder catalysts in research quantities for early product development.

On Nov. 14, 2017, Spectrum Chemical, a US-based chemical manufacturer and distributor, announced that it entered an agreement with BASF, a producer and marketer of chemicals, to provide precious-metal-containing powder catalysts in research quantities to the North American market. According to Spectrum Chemical, this agreement will enable the speed up of commercialization and scale-up production by expanding access to smaller quantities of catalysts needed for early product development.

“We are excited to add these proven catalysts to our industry-leading chemistry portfolio,” said Randy Burg, president and CEO of Spectrum. “Our broad network of customers will receive access to products from the global leader in catalysts, but in the smaller quantities they need for early product development throughout North America.”

Under the agreement, Spectrum will offer 26 BASF catalysts containing precious metals including palladium, platinum, rhodium, and ruthenium, with carriers of carbon, alumina, and calcium carbonate.

Source: Spectrum Chemical

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content